Skip to main content

Amoroso Michael's Form 4 filing

Precision Biosciences Inc (DTIL) · filed Jan 22, 2026

Accession no.
0001628280-26-003149
Filed
Jan 22, 2026
Trade date
Jan 20-22, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $145.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Amoroso MichaelCIK 0001830874Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseAcquired+8,888––124,463Direct
Jan 20, 2026Common StockMOption exerciseAcquired+37,069––161,532Direct
Jan 20, 2026Common StockMOption exerciseAcquired+69,421––230,953Direct
Jan 22, 2026Common StockSSaleDisposed−34,799$4.17−$145,111.83196,154Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 20, 2026Common StockMOption exerciseDisposed−8,888$0.00$00Direct
Jan 20, 2026Common StockMOption exerciseDisposed−37,069$0.00$037,069Direct
Jan 20, 2026Common StockMOption exerciseDisposed−69,421$0.00$069,421Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)